An anti-CD5 monoclonal antibody ameliorates proteinuria and glomerular lesions in rat mesangioproliferative glomerulonephritis

Kidney Int. 2000 Jul;58(1):100-14. doi: 10.1046/j.1523-1755.2000.00145.x.

Abstract

Background: Increased numbers of lymphocytes have been identified in biopsy specimens of human mesangial proliferative glomerulonephritis (GN). However, the causal relationship between infiltrating T lymphocytes and mesangial changes in mesangial proliferative GN has not been previously evaluated. In this study, we elucidated the role of lymphocytes in the development of mesangial proliferative GN.

Method: Immunohistological and flow cytometric analyses as well as a reverse transcription-polymerase chain reaction (RT-PCR) studies were performed in monoclonal antibody (mAb) 1-22-3-induced Thy 1.1 GN. To elucidate the role of these lymphocytes, depletion studies were carried out using anti-CD8 mAb (OX-8), which depletes both CD8+ T lymphocytes and natural killer (NK) cells and anti-CD5 mAb (OX-19), which depletes both CD4+ and CD8+ T lymphocytes.

Results: Immunofluorescence (IF) studies revealed that NK cells and CD4+ T lymphocytes were recruited into glomeruli. Glomerular mRNA expression for interferon-gamma, interleukin-2 (IL-2), IL-10, and perforin increased after induction of GN. Increased expressions of several chemokines, which have the potential to attract lymphocytes, were also detected. Anti-CD8 mAb treatment completely prevented the recruitment of NK cells; however, it had no protective effect on proteinuria and mesangial injury. By contrast, anti-CD5 mAb treatment suppressed the recruitment of CD4+ T lymphocytes into glomeruli and reduced proteinuria (60.4 +/- 25.7 vs. 120.0 +/- 32.3 mg/day, P < 0.05) and mesangial changes evaluated by total number of cells in glomeruli (63.2 +/- 6.0 vs. 81.4 +/- 5.9, P < 0.01) and alpha-smooth muscle actin staining score (1.4 +/- 0.2 vs. 2.2 +/- 0. 4, cf2eth P < 0.01) on day 14 after induction of GN. mRNA expression for IL-2 was significantly reduced by OX-19 treatment.

Conclusion: T lymphocytes participate in the development of mesangial proliferative GN.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antibodies, Monoclonal / pharmacology*
  • CD4-Positive T-Lymphocytes / immunology
  • CD5 Antigens / immunology*
  • CD8-Positive T-Lymphocytes / immunology
  • Cytokines / genetics
  • Cytokines / immunology
  • DNA Primers
  • Female
  • Flow Cytometry
  • Fluorescent Antibody Technique
  • Gene Expression / immunology
  • Glomerulonephritis, Membranoproliferative / immunology
  • Glomerulonephritis, Membranoproliferative / therapy*
  • Immunotherapy
  • Killer Cells, Natural / immunology
  • Lymphocyte Count
  • Macrophages / immunology
  • Proteinuria / immunology
  • Proteinuria / therapy*
  • RNA, Messenger / analysis
  • Rats
  • Rats, Wistar
  • Thy-1 Antigens / immunology

Substances

  • Antibodies, Monoclonal
  • CD5 Antigens
  • Cytokines
  • DNA Primers
  • OX-38 monoclonal antibody
  • RNA, Messenger
  • Thy-1 Antigens